MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

Search

Zoetis Inc

Abierto

SectorSanidad

151.19 -0.39

Resumen

Variación precio

24h

Actual

Mínimo

150.15

Máximo

152.48

Métricas clave

By Trading Economics

Ingresos

-101M

581M

Ventas

-83M

2.3B

P/B

Media del Sector

26.846

57.333

BPA

1.4

Rentabilidad por dividendo

1.35

Margen de beneficios

25.076

Empleados

13,800

EBITDA

-133M

906M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+34.52% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.35%

2.63%

Próximas Ganancias

6 may 2025

Próxima Fecha de Ex Dividendo

16 jul 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-13B

66B

Apertura anterior

151.58

Cierre anterior

151.19

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Zoetis Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

4 nov 2024, 12:47 UTC

Ganancias

Zoetis Lifts Guidance On Strong Demand as 3Q Beats Market Views

6 ago 2024, 11:52 UTC

Ganancias

Zoetis Raises Guidance After 2Q Sales, Earnings Rise

20 feb 2025, 08:00 UTC

Principales Noticias

A Bird-Flu Vaccine Could Bring Down Egg Prices. Why the Poultry Industry Is Fighting It. -- Barrons.com

13 feb 2025, 13:47 UTC

Ganancias

Zoetis Plunges 9% As 2025 Guidance Misses Expectations -- IBD

13 feb 2025, 12:09 UTC

Ganancias

Zoetis Sees FY25 Adj EPS $6-Adj EPS $6.10 >ZTS

13 feb 2025, 12:08 UTC

Ganancias

Zoetis Sees FY25 Rev $9.225B-$9.375B >ZTS

13 feb 2025, 12:08 UTC

Ganancias

Zoetis Sees FY25 EPS $5.70-EPS $5.80 >ZTS

13 feb 2025, 12:00 UTC

Ganancias

Zoetis 4Q EPS $1.29 >ZTS

13 feb 2025, 12:00 UTC

Ganancias

Zoetis 4Q Rev $2.32B >ZTS

13 feb 2025, 12:00 UTC

Ganancias

Zoetis 4Q Net $581M >ZTS

4 nov 2024, 14:05 UTC

Ganancias

Zoetis Barks Up A Third-Quarter Beat And Raise, But Stock Slips -- IBD

4 nov 2024, 12:06 UTC

Ganancias

Zoetis Sees 2024 Rev $9.2B-$9.3B >ZTS

4 nov 2024, 12:06 UTC

Ganancias

Zoetis Sees 2024 Adj EPS $5.86-Adj EPS $5.92 >ZTS

4 nov 2024, 12:05 UTC

Ganancias

Zoetis 3Q Adj EPS $1.58 >ZTS

4 nov 2024, 12:00 UTC

Ganancias

Zoetis 3Q Net $682M >ZTS

4 nov 2024, 12:00 UTC

Ganancias

Zoetis 3Q EPS $1.50 >ZTS

4 nov 2024, 12:00 UTC

Ganancias

Zoetis 3Q Rev $2.39B >ZTS

6 ago 2024, 11:44 UTC

Ganancias

Zoetis Earnings Growth Picks Up, Tops Views -- IBD

6 ago 2024, 11:09 UTC

Ganancias

Zoetis Raises 2024 Operational Revenue Growth View to 9%-11% >ZTS

6 ago 2024, 11:08 UTC

Ganancias

Zoetis Raises 2024 View To Adj EPS $5.78-Adj EPS $5.88 >ZTS

6 ago 2024, 11:08 UTC

Ganancias

Zoetis Raises 2024 View To Rev $9.1B-$9.25B >ZTS

6 ago 2024, 11:08 UTC

Ganancias

Zoetis 2Q Adj EPS $1.56 >ZTS

6 ago 2024, 11:00 UTC

Ganancias

Zoetis 2Q Net $624M >ZTS

6 ago 2024, 11:00 UTC

Ganancias

Zoetis 2Q Rev $2.36B >ZTS

6 ago 2024, 11:00 UTC

Ganancias

Zoetis 2Q EPS $1.37 >ZTS

2 may 2024, 17:43 UTC

Ganancias

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2 may 2024, 13:06 UTC

Ganancias

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2 may 2024, 11:27 UTC

Ganancias

Zoetis Earnings Top; Pet Drugmaker Rises -- IBD

2 may 2024, 11:00 UTC

Ganancias

Zoetis 1Q Net $599M >ZTS

2 may 2024, 11:00 UTC

Ganancias

Zoetis 1Q EPS $1.31 >ZTS

Comparación entre iguales

Cambio de precio

Zoetis Inc previsión

Precio Objetivo

By TipRanks

34.52% repunte

Estimación a 12 Meses

Media 204.88 USD  34.52%

Máximo 242 USD

Mínimo 165 USD

De acuerdo con 8 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Zoetis Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

8 ratings

7

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

147 / 152.64Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Weak Bullish Evidence

Largo Plazo

Bearish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.